Valneva SE (VALN) stock
VALNNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$5.57−0.08 (-1.50%)
Close on Nov 17, 2026Market cap $482.87MP/E –Yield –
Valneva total assets
Total assets on the balance sheet at the end of each period.
Valneva's total assets was €388.28M at Jun 30, 2026. For fiscal 2025 it was €398.84M, down 20.2% from the year before. The highest annual figure on record is €817.35M in fiscal 2021.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | €398.84M | -20.2% |
| FY2024 | Dec 31, 2024 | €500.03M | +8.7% |
| FY2023 | Dec 31, 2023 | €460.06M | -26.0% |
| FY2022 | Dec 31, 2022 | €621.34M | -24.0% |
| FY2021 | Dec 31, 2021 | €817.35M | +82.0% |
| FY2020 | Dec 31, 2020 | €449.16M | – |
Quarterly total assets
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | €388.28M | -17.8% |
| Q1 FY2026 | Mar 31, 2026 | €372.01M | -22.9% |
| Q4 FY2025 | Dec 31, 2025 | €398.84M | -20.2% |
| Q3 FY2025 | Sep 30, 2025 | €448.23M | -13.2% |
| Q2 FY2025 | Jun 30, 2025 | €472.63M | +1.3% |
| Q1 FY2025 | Mar 31, 2025 | €482.24M | -4.1% |
| Q4 FY2024 | Dec 31, 2024 | €500.03M | +8.7% |
| Q3 FY2024 | Sep 30, 2024 | €516.61M | -0.8% |
| Q2 FY2024 | Jun 30, 2024 | €466.57M | -14.0% |
| Q1 FY2024 | Mar 31, 2024 | €502.83M | -14.8% |
| Q4 FY2023 | Dec 31, 2023 | €460.06M | -26.0% |
| Q3 FY2023 | Sep 30, 2023 | €520.54M | -25.4% |
| Q2 FY2023 | Jun 30, 2023 | €542.57M | -25.2% |
| Q1 FY2023 | Mar 31, 2023 | €590.00M | -24.1% |
| Q4 FY2022 | Dec 31, 2022 | €621.34M | -24.0% |
| Q3 FY2022 | Sep 30, 2022 | €698.08M | +55.4% |
| Q2 FY2022 | Jun 30, 2022 | €725.11M | – |
| Q1 FY2022 | Mar 31, 2022 | €777.71M | – |
| Q4 FY2021 | Dec 31, 2021 | €817.35M | – |
| Q4 FY2020 | Dec 31, 2020 | €449.16M | – |
See a number that looks wrong?